UnitedHealth Group (UNH) Stock After Hours Today (23.12.2025): Latest News, Forecasts, and What to Watch Before the Market Opens Tomorrow
24 December 2025
6 mins read

UnitedHealth Group (UNH) Stock After Hours Today (23.12.2025): Latest News, Forecasts, and What to Watch Before the Market Opens Tomorrow

UnitedHealth Group Incorporated (NYSE: UNH) finished Tuesday, December 23, 2025 (23.12.2025) near the $325 level and traded modestly higher in after-hours, as investors head into a holiday-shortened Christmas Eve session with a heavy macro and policy calendar—but no major new company press release late Tuesday.

As of about 4:54 p.m. ET, UNH was indicated around $325.28 in after-hours trading, up modestly from its regular-session finish near $324.80. 1

Below is what matters most for UNH after the bell today and what to keep on your radar before the market opens Wednesday, Dec. 24, 2025—including the key company narratives still driving sentiment, the latest analyst forecasts, and the specific events that could move the tape tomorrow.


UNH stock after the bell: where shares closed and where they’re trading now

UNH ended the regular session on Tuesday near $324.80 and later ticked up to about $325.28 in after-hours trading (as of roughly 4:54 p.m. ET). 1

Tuesday’s intraday range was roughly $323.76 to $327.75, with volume around 3.0 million shares (notably lighter than many recent sessions—typical for the pre-holiday stretch). 1

Why the modest after-hours move matters (even if it looks “small”):

  • With thin holiday liquidity ahead of an early close, even routine headlines can lead to exaggerated price swings.
  • UNH remains one of the market’s most closely watched “policy-sensitive” large caps, because changes in Medicare and broader health insurance rules can reprice future earnings expectations quickly.

The big picture: why UNH is still one of the most debated large-cap stocks into year-end

By many measures, 2025 has been a rough year for UnitedHealth’s stock, and that narrative is still shaping how traders interpret each incremental update.

One prominent market analysis published today described UNH as the Dow’s worst performer in 2025, citing a year defined by controversy, cost pressure, and multiple resets in expectations. 2

Market data trackers also show UNH down about 35.8% year-to-date (as of Tuesday’s update). 3

This matters for tomorrow because heavily-down year-to-date names often trade differently into:

  • Tax-loss selling windows
  • Low-volume holiday sessions
  • Headline-driven “gap risk” (moves that occur between the close and the next open)

Today’s UNH-related developments: what’s new on Dec. 23

There wasn’t an obvious late-day company press release tied to Tuesday’s close. Still, two “today” items are worth noting because they can influence investor perception:

1) SEC filing: CEO Stephen Hemsley disclosed a 55,000-share gift

A Form 4 filed Tuesday shows Stephen J. Hemsley (CEO, UHG) reported a gift of 55,000 shares of UnitedHealth common stock, with a transaction date of 12/19/2025 and a reported price of $0 (typical of gifts). Importantly, the filing indicates it was not an open-market sale. 4

Why it matters for the stock:

  • Even non-sale insider transactions can draw attention in a nervous tape.
  • Some traders treat “insider-related headlines” as sentiment signals during thin liquidity—right or wrong—so it’s worth being aware of.

2) Policy spotlight: Medicare’s AI-powered pre-treatment review pilot begins Jan. 1

Axios reported today that Medicare will begin AI-powered pre-treatment reviews for a limited set of services in select states starting January 1—a significant change for traditional Medicare that has also stirred controversy around prior authorization in Medicare Advantage and commercial plans. 5

Why UNH investors care:

  • While the pilot is not a direct Medicare Advantage rule change, it reinforces that utilization management and authorization practices remain politically and operationally sensitive—especially for large insurers.

The UNH story investors are still digesting heading into tomorrow

Even though some of these developments were reported over the past several days, they remain the core drivers behind the current “why is UNH trading like this?” conversation.

External audits and operational changes: UnitedHealth says reforms are underway

Reuters reported that UnitedHealth said audits by outside consulting firms of parts of its health services and pharmacy benefit operations would lead to operational changes, including greater automation and more standardized internal processes. 6

Reuters also reported CEO Stephen Hemsley told stakeholders there were 23 action plans, with more than half expected to be finalized by the end of 2025 and 100% finalized before the end of Q1 2026. 6

UnitedHealth’s own Independent Review Program page similarly states it is on track to complete 65% of action plans by the end of 2025 and 100% by the end of Q1 2026, and outlines focus areas such as policy governance, tracking corrective actions, risk assessment/coding controls, and manufacturer discount processes. 7

HouseCalls and Medicare Advantage scrutiny remain a key overhang

Reuters highlighted that findings included issues around standardized documentation, including the company’s in-home health assessment program (HouseCalls) and diagnosis submissions tied to Medicare Advantage payment mechanics. 6

Healthcare Dive reported that outside reviewers flagged areas for improvement in documenting and organizing certain policies and coding practices, and noted that the company faces criminal and civil DOJ investigations related to Medicare billing practices—allegations UnitedHealth has denied. 8

UnitedHealth has indicated it plans to share results of a HouseCalls diagnosis-code review in Q1 2026. 7

Why this matters before tomorrow’s open:
UNH is trading in a market where regulatory headlines can create overnight gaps. The “audit → process changes → regulatory/DOJ narrative” chain remains the primary source of that gap risk.


Forecasts and analyst outlook: what Wall Street expectations imply at current prices

Analyst consensus: “Hold” rating, but meaningful upside implied by average target

MarketBeat’s compiled analyst data shows:

  • A consensus rating of “Hold” based on 29 analyst ratings
  • An average 12-month price target of $385.54
  • A wide target range from $198 (low) to $540 (high) 9

At a ~$325 stock price, that consensus target implies high dispersion—analysts broadly disagree on whether the 2025 reset is “mostly priced in” or whether medical-cost and regulatory risks could keep compressing earnings power.

What that dispersion really means for traders going into a holiday session

When price targets are spread this far apart, it usually signals:

  • Higher uncertainty about normalized margins (especially medical cost trend)
  • Greater sensitivity to incremental updates (court, DOJ, CMS, audit follow-through)
  • A market that may “overreact” in low volume—because positioning is cautious

What the options market is saying about near-term volatility

A key question into Wednesday: How big a move is the market pricing over the next few sessions?

One publicly cited expected-move estimate for UNH indicates a roughly ±$8.40 move into the Dec. 26, 2025 expiration window (about 2.57%). 10

Separately, Barchart lists implied volatility around 28.84%, with UNH’s next earnings date shown as 01/27/26. 11

Interpretation (without overpromising precision):

  • The market is not pricing an “earnings-like” shock for tomorrow specifically.
  • But the expected range is still wide enough that a single sharp headline (policy/legal/regulatory) could push UNH toward or through key technical levels.

What to know before the market opens tomorrow (Wednesday, Dec. 24, 2025)

Here’s the practical pre-market checklist for UNH investors and traders.

1) Tomorrow is an early close on Christmas Eve

The NYSE calendar shows markets will close early at 1:00 p.m. ET on Wednesday, Dec. 24, 2025 (with eligible options closing at 1:15 p.m. ET). New York Stock Exchange
Nasdaq’s holiday schedule also lists an early close at 1:00 p.m. on Dec. 24 and a full closure on Dec. 25. 12

What that means for UNH tomorrow:

  • Liquidity tends to fade fast after the open.
  • Moves can look “random” because fewer participants are active.
  • If you’re watching levels, the most meaningful action often happens early.

2) 8:30 a.m. ET: jobless claims data arrives a day early

The U.S. Department of Labor’s schedule shows the weekly Unemployment Insurance (jobless claims) release is scheduled for Wednesday, December 24, 2025 at 8:30 a.m. due to the holiday. 13

Why UNH traders should care:

  • Jobless claims can move index futures and Treasury yields.
  • Even “defensive” stocks like large insurers can be pulled by broad risk-on/risk-off moves—especially in thin holiday trading.

3) Macro tone: today’s data was mixed

Today’s macro headlines included a report that U.S. consumer confidence fell in December (per Reuters’ coverage of the Conference Board data). Reuters
Meanwhile, the BEA’s initial estimate showed Q3 2025 real GDP increased at an annual rate of 4.3%. 14

This mixed macro picture can influence tomorrow’s open—mainly through:

  • Index futures direction
  • Rate expectations
  • Defensive vs. cyclical sector rotation

4) Watch for follow-through (or fatigue) around the audit/DOJ narrative

The audit-driven “process reform” storyline remains front and center (and is likely to remain so into early 2026 as additional review results are published). 7

Tomorrow’s question is less “is there new audit news?” and more:

  • Does the market treat UNH as a stabilizing value story at ~$325?
  • Or does thin liquidity amplify caution around Medicare-related scrutiny?

5) Mark your calendar: next major catalyst is late January

UnitedHealth says it will release full-year 2025 results and 2026 guidance on Tuesday, January 27, 2026, before the market opens, followed by an 8:00 a.m. ET teleconference. 15

That matters now because, in the absence of major daily headlines, traders often position around the next known event where forward guidance can reset the narrative.


Bottom line: the UNH setup going into Dec. 24

UnitedHealth Group stock is ending Dec. 23 with a relatively muted after-hours move—a calm surface that hides a high-sensitivity story. The company’s operational reform timeline, Medicare/authorization scrutiny, and the ACA subsidy debate all remain key macro-policy currents around the stock. 7

For tomorrow’s open (Dec. 24):

  • Expect holiday-thin trading and an early close at 1 p.m. ET. 16
  • Pay attention to the 8:30 a.m. ET jobless claims release, which could set the tone for the entire shortened session. 13
  • Keep an eye on headline risk tied to Medicare practices and regulatory scrutiny, where even incremental updates can move UNH disproportionately in low volume. 8

This article is for informational purposes only and is not investment advice.

Stock Market Today

Sungrow Power Supply (300274.SZ) A-shares: Monday watch after “commercial space” denial

Sungrow Power Supply (300274.SZ) A-shares: Monday watch after “commercial space” denial

8 February 2026
Sungrow closed at 144.50 yuan, down 1.03%, after stating it has no plans in the commercial space sector. Mainland China trading resumes Monday, with Spring Festival closures set for Feb. 15–23. Major funds were net sellers of 5.46 billion yuan on Feb. 6. The Shenzhen-listed solar firm remains under scrutiny as investors await further filings before the holiday.
MPWR stock price hits a new high after Monolithic Power’s outlook — what traders watch next week

MPWR stock price hits a new high after Monolithic Power’s outlook — what traders watch next week

8 February 2026
Monolithic Power Systems shares surged 6.4% to $1,229.82 Friday, hitting a new 52-week high after raising its dividend to $2.00 and forecasting first-quarter revenue of $770 million to $790 million. CEO Michael Hsing filed a Rule 144 notice for 3,082 shares. CFO Bernie Blegen will retire after the 2025 annual report, with Rob Dean named interim CFO. Fourth-quarter revenue rose 20.8% to $751.2 million.
Microchip Technology stock price: MCHP heads into Monday after earnings outlook and mixed analyst calls

Microchip Technology stock price: MCHP heads into Monday after earnings outlook and mixed analyst calls

8 February 2026
Microchip Technology shares fell 2.6% to $76.01 Friday after its outlook and analyst reactions disappointed some investors. The company reported fiscal Q3 net sales up 15.6% to $1.186 billion and guided March-quarter sales to $1.24–$1.28 billion. A global memory shortage has disrupted orders, and analysts remain split on recovery prospects. BlackRock disclosed a 10% stake as of Jan. 31.
Renesas stock price jumps again as $3 billion SiTime deal keeps traders hooked on 6723

Renesas stock price jumps again as $3 billion SiTime deal keeps traders hooked on 6723

8 February 2026
Renesas shares closed at 2,957.5 yen on Friday, up 6.9% after announcing a $3 billion cash-and-stock deal to transfer its timing business to SiTime, with closing targeted by end-2026. Renesas forecast March-quarter revenue of 367.5–382.5 billion yen and a 58.5% gross margin. The company reported 2025 revenue of 1.32 trillion yen and a non-GAAP profit of 329.3 billion yen.
Eli Lilly Stock (LLY) After Hours Today (Dec. 23, 2025): What Happened After the Bell—and What to Watch Before the Market Opens Dec. 24
Previous Story

Eli Lilly Stock (LLY) After Hours Today (Dec. 23, 2025): What Happened After the Bell—and What to Watch Before the Market Opens Dec. 24

Carvana Stock (CVNA) After-Hours Update on Dec. 23, 2025: Key News, Analyst Forecasts, and What to Watch Before Wednesday’s Open
Next Story

Carvana Stock (CVNA) After-Hours Update on Dec. 23, 2025: Key News, Analyst Forecasts, and What to Watch Before Wednesday’s Open

Go toTop